CD4 ⁺ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

Autor: Borgström EW; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: emilie.wahren-borgstrom@sll.se., Fröberg G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: gabrielle.froberg@sll.se., Correia-Neves M; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal. Electronic address: mcorreianeves@med.uminho.pt., Atterfelt FB; Public Health Agency of Sweden, Nobel's väg 18, Solna, Stockholm, Sweden. Electronic address: fredrik.bosdotter.atterfelt@gu.se., Bellbrant J; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: jan.bellbrant@sll.se., Szulkin R; Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, Sweden; Scandinavian Development Services, Danderyd, Sweden. Electronic address: Robert.Szulkin@scanddev.se., Chryssanthou E; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. Electronic address: erja.chryssanthou@sll.se., Ängeby K; Department of Clinical Science and Education, Emergency Medicine, Stockholm South General Hospital, Karolinska Institute, Stockholm, Sweden. Electronic address: kristian.angeby@ki.se., Tecleab T; Public Health Agency of Sweden, Nobel's väg 18, Solna, Stockholm, Sweden. Electronic address: teghesti.tecleab@fohm.se., Ruhwald M; Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark. Electronic address: moru@ssi.dk., Andersen P; Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark. Electronic address: pa@ssi.dk., Källenius G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: gunilla.kallenius@ki.se., Bruchfeld J; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: Judith.Bruchfeld@ki.se.

Publikováno v: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2020 Jul; Vol. 123, pp. 101959. Date of Electronic Publication: 2020 Jun 03.

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.

Autor: Joachim A; 1 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania .; 2 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Stockholm, Sweden ., Munseri PJ; 3 Department of Internal Medicine, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania ., Nilsson C; 2 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Stockholm, Sweden .; 4 Department of Laboratory Medicine, Karolinska Institutet , Huddinge, Sweden .; 5 Public Health Agency of Sweden , Solna, Sweden ., Bakari M; 3 Department of Internal Medicine, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania ., Aboud S; 1 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania ., Lyamuya EF; 1 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania ., Tecleab T; 5 Public Health Agency of Sweden , Solna, Sweden ., Liakina V; 2 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Stockholm, Sweden .; 6 Faculty of Medicine, Vilnius University , Vilnius, Lithuania ., Scarlatti G; 7 Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute , Milan, Italy ., Robb ML; 8 The Military HIV Research Program, The Henry M. Jackson Foundation for the Advancement of Military Medicine , Bethesda, Maryland., Earl PL; 9 National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) , Bethesda, Maryland., Moss B; 9 National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) , Bethesda, Maryland., Wahren B; 2 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Stockholm, Sweden ., Mhalu F; 1 Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS) , Dar es Salaam, Tanzania ., Ferrari G; 10 Department of Surgery and Molecular Genetics and Microbiology, Duke University Medical Center , Durham, North Carolina., Sandstrom E; 11 Venhälsan, Karolinska Institutet , Södersjukhuset, Stockholm, Sweden ., Biberfeld G; 2 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet , Stockholm, Sweden .; 5 Public Health Agency of Sweden , Solna, Sweden .

Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2017 Aug; Vol. 33 (8), pp. 880-888. Date of Electronic Publication: 2017 Jan 27.

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.

Autor: Nilsson C; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden., Hejdeman B; Venhälsan, Department of Education and Clinical Research, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden., Godoy-Ramirez K; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden., Tecleab T; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden., Scarlatti G; Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and infectious diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bråve A; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden., Earl PL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD, United States of America., Stout RR; Bioject Inc., Tigard, Oregon, United States of America., Robb ML; Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland, United States of America., Shattock RJ; Imperial College London, Department of Infectious Diseases, Division of Medicine, Norfolk Place, London, United Kingdom., Biberfeld G; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden., Sandström E; Venhälsan, Department of Education and Clinical Research, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden., Wahren B; Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: PloS one [PLoS One] 2015 Jun 29; Vol. 10 (6), pp. e0131748. Date of Electronic Publication: 2015 Jun 29 (Print Publication: 2015).

Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera.

Autor: Eliadis, Petros, Mais, Annie, Papazisis, Alexandros, Loxa, Eleni K., Dimitriadis, Alexios, Sarrigeorgiou, Ioannis, Backovic, Marija, Agallou, Maria, Zouridakis, Marios, Karagouni, Evdokia, Lazaridis, Konstantinos, Mamalaki, Avgi, Lymberi, Peggy

Publikováno v: Vaccines; Aug2024, Vol. 12 Issue 8, p914, 21p

Development of Nasal Vaccines and the Associated Challenges.

Autor: Nian, Xuanxuan^1,2 (AUTHOR), Zhang, Jiayou^1,2 (AUTHOR), Huang, Shihe^1,2 (AUTHOR), Duan, Kai^1,2 (AUTHOR), Li, Xinguo^1,2 (AUTHOR), Yang, Xiaoming^1,2,3 (AUTHOR) yangxiaoming@sinopharm.com

Publikováno v: Pharmaceutics. Oct2022, Vol. 14 Issue 10, pN.PAG-N.PAG. 26p.